Sponsors 2018

The Organising Committee would like to thank the following companies whose continued support in the provision of unrestricted educational funding has been of great value in establishing the HIV & Hepatitis in the Americas Congress.

2018 PLATINUM SPONSOR

Gilead Logo

Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, USA

 

For over 30 years, Gilead has worked to develop medicines that address areas of unmet medical need for people around the world. Our portfolio of medicines and pipeline of investigational drugs include treatments for HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases and cardiovascular conditions. Every day we strive to transform and simplify care for people with life-threatening illnesses.

2018 GOLD SPONSORS

New MSD

Merck Sharp & Dohme
2000 Galloping Hill Road,
Kenilworth, NJ 07033, USA

 

HIV represents one of the greatest health challenges facing the world today. For 30 years and counting, MSD has been at the forefront of the global response to the HIV epidemic through a three-pronged approach:
1. Working to discover, develop and deliver breakthrough medicines to address both treatment and prevention.
2. Developing an approach to help our products reach as many people as possible.
3. Participating in partnerships with governments, multilateral organizations, community-based organizations, other corporations and non-governmental organizations to help build infrastructure and address health and development challenges around the world.
Through these and other pioneering efforts, MSD is making a substantial contribution toward meeting one of the most critical needs targeted by the United Nations Millennium Development Goals: halting and beginning to reverse the spread of HIV.

ViiV Healthcare
Calzada Mexico Xochimilco #4900,
Col. San Lorenzo Huipulco, Tlalpan
CP 14370 Mexico City, Mexico

ViiV Healthcare is a global specialist HIV company established by GlaxoSmithKline (LSE: GSK. L), Pfizer (NYSE: PFE) and Shionogi (TSE: JSX) to deliver advances in treatment and care for people living with HIV. Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and then take a new approach to deliver effective and new HIV medicines as well as support communities affected by HIV.